Literature DB >> 32554933

Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment.

Uma Shanmugasundaram1, Allison N Bucsan2, Shashank R Ganatra2,3,4, Chris Ibegbu1,5, Melanie Quezada1, Robert V Blair6, Xavier Alvarez2,6, Vijayakumar Velu1,5, Deepak Kaushal2,3,4, Jyothi Rengarajan1,5,7.   

Abstract

Mycobacterium tuberculosis-specific (M. tuberculosis-specific) T cell responses associated with immune control during asymptomatic latent tuberculosis infection (LTBI) remain poorly understood. Using a nonhuman primate aerosol model, we studied the kinetics, phenotypes, and functions of M. tuberculosis antigen-specific T cells in peripheral and lung compartments of M. tuberculosis-infected asymptomatic rhesus macaques by longitudinally sampling blood and bronchoalveolar lavage, for up to 24 weeks postinfection. We found substantially higher frequencies of M. tuberculosis-specific effector and memory CD4+ and CD8+ T cells producing IFN-γ in the airways compared with peripheral blood, and these frequencies were maintained throughout the study period. Moreover, M. tuberculosis-specific IL-17+ and IL-17+IFN-γ+ double-positive T cells were present in the airways but were largely absent in the periphery, suggesting that balanced mucosal Th1/Th17 responses are associated with LTBI. The majority of M. tuberculosis-specific CD4+ T cells that homed to the airways expressed the chemokine receptor CXCR3 and coexpressed CCR6. Notably, CXCR3+CD4+ cells were found in granulomatous and nongranulomatous regions of the lung and inversely correlated with M. tuberculosis burden. Our findings provide insights into antigen-specific T cell responses associated with asymptomatic M. tuberculosis infection that are relevant for developing better strategies to control TB.

Entities:  

Keywords:  Immunology; Infectious disease; Tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 32554933      PMCID: PMC7453885          DOI: 10.1172/jci.insight.137858

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  84 in total

1.  The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates.

Authors:  Justin M Hartings; Chad J Roy
Journal:  J Pharmacol Toxicol Methods       Date:  2004 Jan-Feb       Impact factor: 1.950

2.  Rhesus Macaques Are More Susceptible to Progressive Tuberculosis than Cynomolgus Macaques: a Quantitative Comparison.

Authors:  Philana Ling Lin; Charles A Scanga; JoAnne L Flynn; Pauline Maiello; Robert M DiFazio; Anthony M Cadena; Mark A Rodgers
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

3.  Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung.

Authors:  Yuko Okamoto Yoshida; Masayuki Umemura; Ayano Yahagi; Rebecca L O'Brien; Koichi Ikuta; Kenji Kishihara; Hiromitsu Hara; Susumu Nakae; Yoichiro Iwakura; Goro Matsuzaki
Journal:  J Immunol       Date:  2010-03-08       Impact factor: 5.422

4.  Mucosal-activated invariant T cells do not exhibit significant lung recruitment and proliferation profiles in macaques in response to infection with Mycobacterium tuberculosis CDC1551.

Authors:  Allison N Bucsan; Namita Rout; Taylor W Foreman; Shabaana A Khader; Jyothi Rengarajan; Deepak Kaushal
Journal:  Tuberculosis (Edinb)       Date:  2019-04-26       Impact factor: 3.131

5.  Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.

Authors:  Hui-Min Zhao; Rui Du; Chun-Ling Li; Ping Ji; Hai-Cong Li; Kang Wu; Zhidong Hu; Shui-Hua Lu; Douglas B Lowrie; Xiao-Yong Fan
Journal:  J Infect       Date:  2018-12-05       Impact factor: 6.072

6.  Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates.

Authors:  Alexander G White; Pauline Maiello; M Teresa Coleman; Jaime A Tomko; L James Frye; Charles A Scanga; Philana Ling Lin; JoAnne L Flynn
Journal:  J Vis Exp       Date:  2017-09-05       Impact factor: 1.355

Review 7.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.

Authors:  Clifton E Barry; Helena I Boshoff; Véronique Dartois; Thomas Dick; Sabine Ehrt; JoAnne Flynn; Dirk Schnappinger; Robert J Wilkinson; Douglas Young
Journal:  Nat Rev Microbiol       Date:  2009-10-26       Impact factor: 60.633

8.  Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.

Authors:  Jonathan Kevin Sia; Erica Bizzell; Ranjna Madan-Lala; Jyothi Rengarajan
Journal:  PLoS Pathog       Date:  2017-08-02       Impact factor: 6.823

9.  IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure.

Authors:  Chetan Seshadri; Galit Alter; Lenette L Lu; Malisa T Smith; Krystle K Q Yu; Corinne Luedemann; Todd J Suscovich; Patricia S Grace; Adam Cain; Wen Han Yu; Tanya R McKitrick; Douglas Lauffenburger; Richard D Cummings; Harriet Mayanja-Kizza; Thomas R Hawn; W Henry Boom; Catherine M Stein; Sarah M Fortune
Journal:  Nat Med       Date:  2019-05-20       Impact factor: 53.440

Review 10.  The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease.

Authors:  Allison N Bucsan; Smriti Mehra; Shabaana A Khader; Deepak Kaushal
Journal:  Pathog Dis       Date:  2019-06-01       Impact factor: 3.166

View more
  18 in total

1.  IL-15 Superagonist N-803 Enhances IFN-γ Production of MAIT Cells in SIV+ Macaques.

Authors:  Amy L Ellis-Connell; Alexis J Balgeman; Nadean M Kannal; Karigynn Hansen Chaimson; Anna Batchenkova; Jeffrey T Safrit; Shelby L O'Connor
Journal:  Infect Immun       Date:  2022-10-03       Impact factor: 3.609

2.  Characterizing Early T Cell Responses in Nonhuman Primate Model of Tuberculosis.

Authors:  Riti Sharan; Dhiraj Kumar Singh; Jyothi Rengarajan; Deepak Kaushal
Journal:  Front Immunol       Date:  2021-08-17       Impact factor: 8.786

3.  Th22 Cells Are a Major Contributor to the Mycobacterial CD4+ T Cell Response and Are Depleted During HIV Infection.

Authors:  Rubina Bunjun; Fidilia M A Omondi; Mohau S Makatsa; Roanne Keeton; Jerome M Wendoh; Tracey L Müller; Caryn S L Prentice; Robert J Wilkinson; Catherine Riou; Wendy A Burgers
Journal:  J Immunol       Date:  2021-08-13       Impact factor: 5.422

4.  Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease.

Authors:  Gabriele Pollara; Carolin T Turner; Joshua Rosenheim; Aneesh Chandran; Lucy C K Bell; Ayesha Khan; Amit Patel; Luis Felipe Peralta; Anna Folino; Ayse Akarca; Cristina Venturini; Tina Baker; Simone Ecker; Fabio L M Ricciardolo; Teresa Marafioti; Cesar Ugarte-Gil; David A J Moore; Benjamin M Chain; Gillian S Tomlinson; Mahdad Noursadeghi
Journal:  Sci Transl Med       Date:  2021-05-05       Impact factor: 17.956

5.  Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung.

Authors:  Paul Ogongo; Liku B Tezera; Amanda Ardain; Shepherd Nhamoyebonde; Duran Ramsuran; Alveera Singh; Abigail Ng'oepe; Farina Karim; Taryn Naidoo; Khadija Khan; Kaylesh J Dullabh; Michael Fehlings; Boon Heng Lee; Alessandra Nardin; Cecilia S Lindestam Arlehamn; Alessandro Sette; Samuel M Behar; Adrie Jc Steyn; Rajhmun Madansein; Henrik N Kløverpris; Paul T Elkington; Alasdair Leslie
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 19.456

6.  Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease.

Authors:  Ju Mi Lee; Jiyun Park; Steven G Reed; Rhea N Coler; Jung Joo Hong; Lee-Han Kim; Wonsik Lee; Kee Woong Kwon; Sung Jae Shin
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

7.  Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.

Authors:  Susan L Baldwin; Valerie A Reese; Sasha E Larsen; Elyse Beebe; Jeff Guderian; Mark T Orr; Christopher B Fox; Steven G Reed; Rhea N Coler
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.752

8.  Reduced CCR6+IL-17A+Treg Cells in Blood and CCR6-Dependent Accumulation of IL-17A+Treg Cells in Lungs of Patients With Allergic Asthma.

Authors:  Xiaokun Shen; Huiyun Zhang; Hua Xie; Liping Chen; Shinan Li; Junjuan Zheng; Ruonan Chai; Zhao Wang; Yanyan Zang; Shaoheng He
Journal:  Front Immunol       Date:  2021-08-23       Impact factor: 7.561

Review 9.  Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics.

Authors:  Ana B Enriquez; Angelo Izzo; Shannon M Miller; Erica L Stewart; Robert N Mahon; Daniel J Frank; Jay T Evans; Jyothi Rengarajan; James A Triccas
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 8.786

10.  Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model.

Authors:  Shashank R Ganatra; Allison N Bucşan; Xavier Alvarez; Shyamesh Kumar; Ayan Chatterjee; Melanie Quezada; Abigail Fish; Dhiraj K Singh; Bindu Singh; Riti Sharan; Tae-Hyung Lee; Uma Shanmugasundaram; Vijayakumar Velu; Shabaana A Khader; Smriti Mehra; Jyothi Rengarajan; Deepak Kaushal
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.